Literature DB >> 14977932

Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.

Maria Angeles Gomez Morales1, Raffaella Mele, Alessandra Ludovisi, Fabrizio Bruschi, Fabio Tosini, Rachele Riganò, Edoardo Pozio.   

Abstract

T-cell-mediated immunity plays a central role in the host response to Cryptosporidium parvum. Human T-cell clones (TCC) were isolated from peripheral blood mononuclear cells of five healthy donors with prior cryptosporidiosis by use of a C. parvum crude extract, two antigen fractions obtained by ion-exchange chromatography (IEC1 and IEC2), and two recombinant peptides (SA35 and SA40) from C. parvum sporozoites. The T-cell lines derived from the one recently infected donor had a higher proportion (26 to 38%) of T cells exhibiting the gamma/delta T-cell receptor (gamma/delta-TCR) than those from donors who had recovered from cryptosporidiosis several years earlier, suggesting that the gamma/delta T-cell population is involved in the early stage of the infection. The specific TCC had the alpha/beta-TCR, had the phenotype CD45RO(+) CD4(+) CD8(-), and were characterized by either hyperproduction of gamma interferon (IFN-gamma) alone, with a Th1 profile, or IFN-gamma hyperproduction together with interleukin-4 (IL-4) or IL-5 production, with a Th0 profile. SA35, SA40, IEC1, and IEC2 may be considered good targets of the cellular response against C. parvum and may play a role in maintaining the T-cell-mediated memory response to this parasite. Furthermore, the SA35 and SA40 peptides may be regarded as immunodominant antigens involved in the maintenance of the T-cell response in healthy C. parvum-sensitized persons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977932      PMCID: PMC356036          DOI: 10.1128/IAI.72.3.1306-1310.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage.

Authors:  Fabio Tosini; Alessia Agnoli; Raffaella Mele; Maria Angeles Gomez Morales; Edoardo Pozio
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

Review 2.  Humoral and cellular immunity against Cryptosporidium infection.

Authors:  Maria Angeles Gomez Morales; Edoardo Pozio
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2002-10

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.

Authors:  J F Rossignol; A Ayoub; M S Ayers
Journal:  J Infect Dis       Date:  2001-05-29       Impact factor: 5.226

6.  Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.

Authors:  Beatrice Amadi; Mwiya Mwiya; John Musuku; Angela Watuka; Sandie Sianongo; Ayman Ayoub; Paul Kelly
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 7.  The role of cytokines in the pathogenesis of Cryptosporidium infection.

Authors:  Inez-Sarah Lean; Vincent McDonald; Richard C G Pollok
Journal:  Curr Opin Infect Dis       Date:  2002-06       Impact factor: 4.915

8.  Cellular profile of cytokine production in a patient with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines and interleukin-10.

Authors:  H Lagler; M Willheim; F Traunmüller; K Wahl; H Winkler; M Ramharter; W Graninger; S Winkler
Journal:  Scand J Immunol       Date:  2003-03       Impact factor: 3.487

9.  Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.

Authors:  R Mele; M A Gomez Morales; F Tosini; E Pozio
Journal:  Int J Parasitol       Date:  2003-07       Impact factor: 3.981

10.  Human infection with Cryptosporidium felis: case report and literature review.

Authors:  Simone Cacciò; Elena Pinter; Rosanna Fantini; Ivano Mezzaroma; Edoardo Pozio
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  9 in total

1.  Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection.

Authors:  I-Sarah Lean; Sonia Lacroix-Lamandé; Fabrice Laurent; Vincent McDonald
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 3.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 4.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

5.  TLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis.

Authors:  Steven P O'Hara; Pamela S Tietz Bogert; Christy E Trussoni; Xianming Chen; Nicholas F LaRusso
Journal:  J Parasitol       Date:  2011-03-23       Impact factor: 1.276

6.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21

Review 7.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

8.  Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection.

Authors:  Fabio Tosini; Alessandra Ludovisi; Daniele Tonanzi; Marco Amati; Simona Cherchi; Edoardo Pozio; Maria Angeles Gómez-Morales
Journal:  Parasit Vectors       Date:  2019-05-15       Impact factor: 3.876

9.  Enterocyte-innate lymphoid cell crosstalk drives early IFN-γ-mediated control of Cryptosporidium.

Authors:  Jodi A Gullicksrud; Adam Sateriale; Julie B Engiles; Alexis R Gibson; Sebastian Shaw; Zachary A Hutchins; Lindsay Martin; David A Christian; Gregory A Taylor; Masahiro Yamamoto; Daniel P Beiting; Boris Striepen; Christopher A Hunter
Journal:  Mucosal Immunol       Date:  2021-11-08       Impact factor: 8.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.